.svg)
.svg)
.svg)
.svg)
.svg)
I've spent years at the intersection of nutrigenetics, food science, and technology. The longer I sit here, the more convinced I become of one thing: the food and nutrition industry is making consequential decisions on structurally inadequate data.
I've spent years at the intersection of nutrigenetics, food science, and technology. The longer I sit here, the more convinced I become of one thing: the food and nutrition industry is making consequential decisions on structurally inadequate data.
That's not a criticism of the scientists or the formulators. Most of them are brilliant. It's a criticism of the systems — the disconnected databases, the siloed research, the one-size-fits-all assumptions baked into product development from the very first ingredient brief.
We can do better. We have to.
When people talk about personalized nutrition, they usually mean preferences. Keto versus plant-based. High-protein versus low-carb. That's not personalization. That's segmentation.
Real personalization starts at the genetic level.
A September 2026 review published in Frontiers in Nutrition examined AI applications in personalized nutrition interventions and found that genetic variation, microbiome composition, and metabolic response patterns collectively explain why two people eating the same meal can have dramatically different health outcomes. The review reinforces what nutrigenetics researchers have argued for years: population-level dietary guidelines are averages, and averages obscure the people on either end of the distribution.
The Monell Chemical Senses Center published research on taste and smell gene variants that makes this point hard to dismiss. Variants in the genes governing onion flavor perception are associated with differential blood pressure and diabetes risk — not because onions are magic, but because genetic variation in sensory perception shapes food preference, food preference shapes diet, and diet shapes long-term metabolic health. The chain runs deeper than most product developers consider.
Then there's the August 2026 Nature paper analyzing FNIP1 gene variants across approximately 1 million humans. The findings point to meaningful differences in metabolic function across populations — differences that don't show up in any standard nutritional panel, any current RDA, or any ingredient specification sheet.
These aren't edge cases. They're the norm. Human biology is variable. Our food system largely pretends it isn't.
According to Grand View Research, the personalized nutrition and supplements market was valued at USD 15.97 billion in 2025 and is projected to reach USD 48.57 billion by 2033, growing at a 15.03% CAGR. Mordor Intelligence puts the nutrigenomics market on a similar trajectory, projecting roughly 15% CAGR from 2026 through 2031.
Consumers are voting with their wallets. They want products built for them, not for a demographic average.
The problem is that food industry product development wasn't designed to respond to that demand at scale. Most R&D teams are still working from ingredient databases that don't talk to supplier systems, formulation tools that don't connect to nutritional scoring, and procurement workflows with no visibility into sustainability or risk data. Personalization at the product level requires connecting all of those layers simultaneously — and right now, most teams are stitching them together manually, if at all.
That's the gap I built Journey Foods to address.
Here's where I want to push back on how this conversation usually goes.
Most of the attention lands on the consumer-facing end: DNA testing kits, personalized supplement subscriptions, microbiome analysis apps. Those are valuable. But they represent one layer of a much deeper problem.
If a consumer gets a nutrigenomic report recommending higher magnesium intake and lower refined carbohydrates, what happens next? They buy a product. That product was formulated by a CPG team that had no idea this consumer existed, working from a brief that optimized for cost and shelf stability, using ingredient data that may not have included full micronutrient profiles, sourced from a supplier whose traceability documentation is three emails deep in someone's inbox.
The personalization chain breaks at the product-development level.
This is why the real frontier isn't just better consumer data. It's better product data — ingredient data, formulation data, nutritional data, and supply-chain data — unified and queryable in a way that lets food companies actually respond to what the science is telling us about human variation.
At Journey Foods, the platform's Operations Scientist technology was built on exactly this thesis: that evaluating an ingredient or formulation requires scoring it simultaneously across nutrition, cost, sustainability, sourcing risk, and quality — not sequentially, not in separate tools, not by a single expert working from memory. Not because that's a convenient feature set, but because those dimensions are genuinely interdependent. A high-protein ingredient that scores well on PDCAAS but carries supply concentration risk in a single geography isn't a clean win. A clean-label formulation that hits the fiber target but misses on cost parity isn't ready to scale.
Personalization at the product level demands that kind of multi-criteria thinking. And multi-criteria thinking demands connected data.
I want to be precise here, because "more data" is easy to say and hard to mean.
More data doesn't mean more noise. It doesn't mean another database subscription or another column in a spreadsheet. It means connecting the data layers that are currently isolated from each other — genetic research, ingredient science, formulation outcomes, supplier performance, nutritional analysis — so that decisions at any one layer are informed by what's happening in the others.
The Frontiers in Nutrition review makes this point structurally: the most effective AI-driven personalized nutrition interventions are the ones that integrate multiple data types, not the ones that optimize a single variable. That's as true for a CPG product development team as it is for a clinical nutrition researcher.
The question isn't whether personalization matters. The science has answered that. The question is whether the infrastructure exists to act on it — at the speed and scale that product development actually requires.
For most teams right now, it doesn't. The data exists in fragments. The connections between fragments are manual. And the decisions that should be informed by all of it get made on whichever fragment is most accessible.
I started Journey Foods because I believed — and still believe — that food companies deserve the same quality of connected, multi-criteria data intelligence that other industries take for granted. Not to replace food scientists. Not to automate formulation. But to give the people doing that work a system that reflects the actual complexity of what they're deciding.
The science on human biological variation is getting sharper every year. The market demand for products that reflect that variation is growing at a rate that Grand View Research and Mordor Intelligence are both tracking in the double digits. The gap between what the science knows and what the food system delivers is not closing on its own.
It closes when the data infrastructure catches up to the biology.
That's the work. And it's worth doing.
What is personalized nutrition and why does it matter for CPG product development?
Personalized nutrition refers to dietary and product recommendations tailored to individual biological variation — including genetics, microbiome composition, and metabolic response. For CPG product development, it matters because consumer demand for targeted nutrition is growing rapidly, and products formulated on generic population averages are increasingly misaligned with what buyers want and what the science supports.
How do genetic variants affect nutrition and food product outcomes?
Genetic variants can influence how individuals metabolize macronutrients, respond to specific bioactive compounds, and even perceive taste and smell — which in turn shapes dietary preference and long-term health. Research from the Monell Chemical Senses Center has shown that variants in sensory perception genes are associated with measurable differences in metabolic health outcomes.
Why is siloed data a problem in food and nutrition R&D?
When ingredient data, nutritional analysis, supplier information, and formulation history live in separate systems, teams make decisions based on incomplete pictures. A formulation that looks strong on nutrition may carry hidden supply-chain risk. A cost-optimized ingredient may underperform on sustainability scoring. Connecting those layers is what makes informed, multi-criteria decisions possible.
What is the Operations Scientist technology in Journey Foods?
The Operations Scientist is Journey Foods' core scoring engine. It evaluates ingredients simultaneously across nutrition, cost, sustainability, sourcing risk, and quality criteria — rather than optimizing for one dimension at a time. The goal is to surface trade-offs and opportunities that single-variable analysis misses.
Is Journey Foods a consumer DNA testing or nutrigenomics platform?
No. Journey Foods is a B2B ingredient and formulation intelligence platform for food, beverage, supplement, and CPG companies. It does not collect or analyze individual consumer genetic data. The platform operates at the product-development level — helping R&D, procurement, and operations teams make better decisions about ingredients, formulations, and supply chains.
What is driving growth in the personalized nutrition market?
According to Grand View Research, the personalized nutrition and supplements market is projected to grow from USD 15.97 billion in 2025 to USD 48.57 billion by 2033, at a 15.03% CAGR. Mordor Intelligence projects similar growth in the nutrigenomics segment. Increased consumer awareness of biological individuality, advances in genetic research, and the proliferation of direct-to-consumer health tools are all contributing factors.
How can food companies start closing the gap between nutrition science and product development?
The most practical starting point is data integration — connecting ingredient, formulation, nutritional, and supply-chain data so that product decisions are informed by all relevant criteria simultaneously. From there, teams can begin incorporating emerging research on biological variation into ingredient selection and formulation strategy, rather than treating those as separate workstreams.
